Prescience Point Capital Management Issues Negative Research Report on Enphase Energy, Inc. (NASDAQ: ENPH)

Rhea-AI Summary

On June 17, 2020, Prescience Point Capital Management released a negative research report on Enphase Energy, Inc. (NASDAQ: ENPH), claiming the company's reported financial performance is misleading. The report alleges that 39% of U.S. revenue, around $205 million, may be fabricated, suggesting potential accounting violations. Prescience Point predicts government investigations, shareholder lawsuits, and possible delisting of ENPH shares from NASDAQ. The report also indicates that executives were aware of the investigation, evidenced by significant stock sales.

Positive

• None.

Negative

• 39% of reported US revenue, approximately $205 million, may be fabricated.
• Potential accounting violations linked to international revenue.
• Predicted government investigations could harm investor confidence.
• Shareholder lawsuits may arise from the misleading financial reports.
• Risk of delisting from NASDAQ due to financial discrepancies.

BATON ROUGE, La., June 17, 2020 /PRNewswire/ -- Prescience Point Capital Management ("Prescience Point"), a private investment manager that focuses on investigations of public companies, published a negative research report today supporting its short position in shares of Enphase Energy, Inc. (NASDAQ: ENPH), a maker of microinverter systems for residential and commercial use based in Petaluma, CA.

Prescience Point has been closely scrutinizing Enphase for over two years and we believe the company's financial performance has become increasingly disconnected from reality since our initial reports were published in July 2018 and August 2018. Following our latest investigation, which included interviews of numerous former employees, we believe that Enphase's financial reports are not reliable, and that the 4,653% increase in its share price since CEO Badri Kothandaraman was promoted to CEO is unwarranted. 

"The explosive growth that Enphase has reported to investors over the last two years is nothing but a sham which has lined the pockets of those at the top of the company," said Eiad Asbahi, Founder and Portfolio Manager of Prescience Point. "We believe the evidence presented in our report will result in multiple government investigations, a major accounting restatement, shareholder lawsuits and a delisting of ENPH shares from the NASDAQ."

Our research suggests that at least 39%, or $205 million, of US revenue reported by the company is potentially fabricated, as is a significant portion of the company's international revenue. Multiple former employees in India independently told our private investigators that Enphase was fabricating figures it reports publicly, and that the company is using overseas operations to help executives perpetrate potential accounting violations. 

Our research also suggests that Enphase executives and board members, as well as its previous largest shareholder, likely learned of the existence of our private investigation.  This is supported by the unprecedented number of shares these parties sold from late-May to mid-June, which is right around the time that our private investigation had wrapped up.  Their timing and shear magnitude of sales appears to be a rush for the exits ahead of Enphase's coming downfall. 

Click here to download Prescience Point's full report on Enphase [insert link].

Prescience Point has a short position in Enphase and stands to benefit if its share price falls.

About Prescience Point Capital Management
Prescience Point Capital Management is a private investment manager that employs forensic investigative techniques to unearth significant mispricings in global markets. The firm specializes in extensive investigations of difficult-to-analyze public companies in order to uncover significant elements of the business that have been overlooked or ignored by others. Their publicly-available research focuses on exposing corporate wrongdoing and has been followed by resignations of auditors, CEOs and CFOs, earnings restatements, SEC investigations and stock delistings.

Prescience Point manages private funds on behalf of clients and principals and takes positions both long and short in support of their research. The firm invests across a broad set of equities that they believe have abnormally large disparities between what their underlying businesses are intrinsically worth and what their securities sell for.

The firm was founded by investor Eiad Asbahi in 2009 and is headquartered in Baton Rouge, LA. Prescience Point Capital Management is a registered investment advisor with the State of Louisiana a member of the Financial Industry Regulatory Authority, CRD number 152721. For updates follow Prescience Point on Twitter @PresciencePoint

Disclaimer
THIS RELEASE EXPRESSES SOLELY PRESCIENCE POINT CAPITAL MANAGEMENT'S OPINIONS. Use Prescience Point's research opinions at your own risk. This is not investment advice nor should it be construed as such. You should do your own research and due diligence before making any investment decisions with respect to the securities covered herein. Forward-looking statement and projections are inherently susceptible to uncertainty and involve many risks (known and unknown) that could cause actual results to differ materially from expected results. You should assume we have a short interest in Enphase Energy stock and therefore stand to realize significant gains in the event that the price of such instrument declines. Please refer to our full disclaimer located on the last page of our research report (linked herein).

View original content:http://www.prnewswire.com/news-releases/prescience-point-capital-management-issues-negative-research-report-on-enphase-energy-inc-nasdaq-enph-301078647.html

SOURCE Prescience Point Capital Management

FAQ

What does the Prescience Point report say about Enphase Energy's revenue?

The report claims that 39% of Enphase's reported US revenue, around $205 million, may be fabricated.

What are the expected consequences for Enphase Energy following the Prescience Point report?

The report predicts government investigations, shareholder lawsuits, and potential delisting from NASDAQ.

How has Enphase Energy's stock performance been affected by the Prescience Point report?

The report suggests that the substantial share price increase under CEO Badri Kothandaraman is unwarranted and could lead to a decline.

What does Prescience Point Capital Management claim about Enphase Energy's financial reports?

They allege that Enphase's financial reports are unreliable and disconnected from reality.

What is the significance of the insider stock sales mentioned in the report?

The report highlights that Enphase executives sold a significant number of shares shortly after the private investigation wrapped up, indicating a rush to exit.